Skip to content

Medinet is a total solution provider for cell processing, including contract manufacturing of specific cell processed products (CMO) and development/manufacturing of regenerative medicine products (CDMO).

Last updated September 1, 2026

AI crawler reads

2requests

1companies
  • Anthropic2
Profile
2
Controversies
0
JSON · MD
0
First read
Nov 4, 2026
Latest read
Nov 4, 2026

From this site's server log

Overview

Medinet Co., Ltd. is a Japanese company established in October 1995. It provides total solutions for cell processing, including contract manufacturing of specific cell processed products (CMO) and development/manufacturing of regenerative medicine products (CDMO). The company also offers value chain services and operates a self-cancer tissue bank.

History

Medinet was established in October 1995 in Minato-ku, Tokyo, with the aim of providing new medical services based on preventive medicine. In 1999, it opened the Molecular Immunology Laboratory and began supporting immunotherapy. The company was listed on the Tokyo Stock Exchange Mothers market in October 2003. In 2004, it started the 'Self-Cancer Tissue Bank' service. Over the years, it has expanded its facilities and services, including obtaining manufacturing permits for specific cell processed products and entering into various contracts and collaborations.

Sources4 sources

Cite this profile: Cite the canonical profile. /brand-wiki/medinet · Editorial policy · How profiles are compiled